Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Contrast MRI”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Early research (Phase 1)Study completedNCT05413668
What this trial is testing

First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent

Who this might be right for
Healthy
Reveal Pharmaceuticals Inc. 32
Large-scale testing (Phase 3)Study completedNCT00307866
What this trial is testing

Identification of Hepatic Lesions

Who this might be right for
Hepatic Neoplasms
Bayer 218
Not applicableLooking for participantsNCT06502431
What this trial is testing

Analysis of Disturbances in Neurofluid Dynamics in Type I Chiari Malformations

Who this might be right for
Type I Chiari MalformationCerebral HemodynamicCraniospinal Hydrodynamic+2 more
Centre Hospitalier Universitaire, Amiens 60
Post-approval studies (Phase 4)Study completedNCT00323102
What this trial is testing

A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain

Who this might be right for
Brain Pathology
Bracco Diagnostics, Inc 114
Large-scale testing (Phase 3)Study completedNCT01660841
What this trial is testing

Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging

Who this might be right for
Magnetic Resonance Imaging
Bayer 223
Not applicableEnded earlyNCT01799135
What this trial is testing

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Dana-Farber Cancer Institute 6
Not applicableStudy completedNCT03669055
What this trial is testing

Hemodynamic Changes in the Aorta After Endovascular Treatment of the Aortic Dissection

Who this might be right for
Aortic Dissection
Hospices Civils de Lyon 5
Large-scale testing (Phase 3)Study completedNCT00209443
What this trial is testing

A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide

Who this might be right for
Aorto-iliac StenosisArterial Occlusive Diseases
GE Healthcare 407
Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Not applicableStudy completedNCT00575692
What this trial is testing

Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionVentricular FunctionMR Phase Contrast Velocity Imaging+1 more
Medical University of Graz 240
Early research (Phase 1)Study completedNCT00610493
What this trial is testing

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 193
Large-scale testing (Phase 3)Study completedNCT01260636
What this trial is testing

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

Who this might be right for
Carotid, Aortic, Renal or Peripheral Artery Disease
Bracco Diagnostics, Inc 120
Not applicableStudy completedNCT03723512
What this trial is testing

Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study

Who this might be right for
C3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative Glomerulonephritis+2 more
Mario Negri Institute for Pharmacological Research 7
Large-scale testing (Phase 3)Study completedNCT00526188
What this trial is testing

Efficacy and Safety of Primovist in Chinese Patients

Who this might be right for
Known or Suspected Focal Liver Lesions
Bayer 234
Not applicableUnknownNCT02578303
What this trial is testing

Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations

Who this might be right for
Alzheimer Disease
Central Hospital Saint Quentin 139
Large-scale testing (Phase 3)Study completedNCT05915728
What this trial is testing

Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Who this might be right for
Contrast Enhancement in Magnetic Resonance ImagingNon-central Nervous System Pathology
Bayer 410
Not applicableEnded earlyNCT01599832
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
University of Chicago 20
Large-scale testing (Phase 3)Study completedNCT07275723
What this trial is testing

A Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

Who this might be right for
For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)
Shanghai Shengdi Pharmaceutical Co., Ltd 309
Early research (Phase 1)WithdrawnNCT01741597
What this trial is testing

Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more
City of Hope Medical Center
Next Page